Wuhan YZY Biopharma Co., Ltd. (HKG:2496)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.200
-0.005 (-0.23%)
Oct 9, 2026, 9:42 AM HKT

Wuhan YZY Biopharma Statistics

Total Valuation

HKG:2496 has a market cap or net worth of HKD 484.62 million. The enterprise value is 556.95 million.

Market Cap484.62M
Enterprise Value 556.95M

Important Dates

The next estimated earnings date is Friday, November 27, 2026.

Earnings Date Nov 27, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2496 has 193.85 million shares outstanding.

Current Share Class 179.48M
Shares Outstanding 193.85M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 19.52%
Owned by Institutions (%) 8.61%
Float 22.73M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.20
PB Ratio -7.17
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.28
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.55

Current Ratio 0.55
Quick Ratio 0.50
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -2.08
Interest Coverage -5.64

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -7.87%
Return on Invested Capital (ROIC) -15.67%
Return on Capital Employed (ROCE) 44.81%
Weighted Average Cost of Capital (WACC) 5.83%
Revenue Per Employee 989,162
Profits Per Employee -545,964
Employee Count68
Asset Turnover 0.28
Inventory Turnover 11.38

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -67.60% in the last 52 weeks. The beta is 0.48, so HKG:2496's price volatility has been lower than the market average.

Beta (5Y) 0.48
52-Week Price Change -67.60%
50-Day Moving Average 3.41
200-Day Moving Average 5.13
Relative Strength Index (RSI) 22.31
Average Volume (20 Days) 70

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2496 had revenue of HKD 67.26 million and -37.13 million in losses. Loss per share was -0.19.

Revenue67.26M
Gross Profit 27.44M
Operating Income -30.29M
Pretax Income -37.13M
Net Income -37.13M
EBITDA -26.34M
EBIT -30.29M
Loss Per Share -0.19
Full Income Statement

Balance Sheet

The company has 87.74 million in cash and 160.06 million in debt, with a net cash position of -72.33 million or -0.37 per share.

Cash & Cash Equivalents 87.74M
Total Debt 160.06M
Net Cash -72.33M
Net Cash Per Share -0.37
Equity (Book Value) -67.60M
Book Value Per Share -0.35
Working Capital -121.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -69.74 million and capital expenditures -7.03 million, giving a free cash flow of -76.77 million.

Operating Cash Flow -69.74M
Capital Expenditures -7.03M
Depreciation & Amortization 4.02M
Net Borrowing -21.29M
Free Cash Flow -76.77M
FCF Per Share -0.40
Full Cash Flow Statement

Margins

Gross margin is 40.80%, with operating and profit margins of -45.04% and -55.19%.

Gross Margin 40.80%
Operating Margin -45.04%
Pretax Margin -55.19%
Profit Margin -55.19%
EBITDA Margin -39.16%
EBIT Margin -45.04%
FCF Margin n/a

Dividends & Yields

HKG:2496 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -7.66%
FCF Yield -15.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2496 has an Altman Z-Score of -2.96. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.96
Piotroski F-Score n/a